Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Hsi

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
Nature Communications|November 9, 2019
Tissue-specific microRNA expression alters cancer susceptibility conferred by a TP53 noncoding variantQipan Deng, Hui Hu, Xinfang Yu, et al.
Journal of the National Cancer Institute|December 18, 2016
General Biomarker Recommendations for LymphomaLisa Rimsza, Yuri Fedoriw, Louis M Staudt, et al.
Leukemia Research|April 30, 2010
A Phase 1 study of imatinib mesylate in combination with cytarabine and daunorubicin for c-kit positive relapsed acute myeloid leukemiaAnjali S Advani, Ramon Tiu, Yogen Saunthararajah, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 20, 2011
Pralatrexate in patients with relapsed or refractory peripheral T-cell lymphoma: results from the pivotal PROPEL studyOwen A O'Connor, Barbara Pro, Lauren Pinter-Brown, et al.
The Journal of Clinical Investigation|January 27, 2015
Evaluation of noncytotoxic DNMT1-depleting therapy in patients with myelodysplastic syndromesYogen Saunthararajah, Mikkael Sekeres, Anjali Advani, et al.
The Journal of Clinical Investigation|August 1, 2017
GATA4 loss of function in liver cancer impedes precursor to hepatocyte transitionFrancis O Enane, Wai Ho Shuen, Xiaorong Gu, et al.
Blood Advances|December 5, 2025
Proinflammatory GSDMD activation in live macrophages and DLBCL cells marks cognate interactions and better prognosisXue Kong, Zijun Y Xu-Monette, Zhenming Xu, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 15, 2021
NCCN Guidelines® Insights: B-Cell Lymphomas, Version 5.2021Andrew D Zelenetz, Leo I Gordon, Julie E Chang, et al.
Research Square|January 27, 2025
Prognostic gene expression and microRNA profiling signatures and genetic alterations in primary testicular diffuse large B-cell lymphomaKen Young, Wen-Yu Shi, Zijun Xu-Monette, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Nature Communications|November 9, 2019
Tissue-specific microRNA expression alters cancer susceptibility conferred by a TP53 noncoding variantQipan Deng, Hui Hu, Xinfang Yu, et al.
Journal of the National Cancer Institute|December 18, 2016
General Biomarker Recommendations for LymphomaLisa Rimsza, Yuri Fedoriw, Louis M Staudt, et al.
Leukemia Research|April 30, 2010
A Phase 1 study of imatinib mesylate in combination with cytarabine and daunorubicin for c-kit positive relapsed acute myeloid leukemiaAnjali S Advani, Ramon Tiu, Yogen Saunthararajah, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 20, 2011
Pralatrexate in patients with relapsed or refractory peripheral T-cell lymphoma: results from the pivotal PROPEL studyOwen A O'Connor, Barbara Pro, Lauren Pinter-Brown, et al.
The Journal of Clinical Investigation|January 27, 2015
Evaluation of noncytotoxic DNMT1-depleting therapy in patients with myelodysplastic syndromesYogen Saunthararajah, Mikkael Sekeres, Anjali Advani, et al.
The Journal of Clinical Investigation|August 1, 2017
GATA4 loss of function in liver cancer impedes precursor to hepatocyte transitionFrancis O Enane, Wai Ho Shuen, Xiaorong Gu, et al.
Blood Advances|December 5, 2025
Proinflammatory GSDMD activation in live macrophages and DLBCL cells marks cognate interactions and better prognosisXue Kong, Zijun Y Xu-Monette, Zhenming Xu, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 15, 2021
NCCN Guidelines® Insights: B-Cell Lymphomas, Version 5.2021Andrew D Zelenetz, Leo I Gordon, Julie E Chang, et al.
Research Square|January 27, 2025
Prognostic gene expression and microRNA profiling signatures and genetic alterations in primary testicular diffuse large B-cell lymphomaKen Young, Wen-Yu Shi, Zijun Xu-Monette, et al.
Pageof 4